It would be hard to beat 2000 as a major milestone year for scientific achievement and market recognition of genomics as the new frontier. With the human genome sequenced and bioinformatics companies raising big bucks in the capital markets for the first time, the sector sure had a lot to celebrate.

As we head into 2001 the future doesn’t look quite so bright. A recession looms and scientists must now work out loads of kinks in order to realize genomics’ promise. Nevertheless, industry experts are looking forward to another fun year ahead.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.